Giulia Bottai

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

András Lánczky, Ádám Nagy, Giulia Bottai et al. · Breast Cancer Research and Treatment · 2016 · 811 citations

Medicine, Bioinformatics, Oncology +16

A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients

Kristine Kleivi Sahlberg, Giulia Bottai, Bjørn Naume et al. · Clinical Cancer Research · 2014 · 230 citations · Full text

Medicine, Molecular Medicine, Oncology +17

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

Leticia De Mattos‐Arruda, Giulia Bottai, Paolo Nucíforo et al. · Oncotarget · 2015 · 152 citations · Full text

Medicine, Cancer Biology, Oncology +17

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

Giulia Bottai, Carlotta Raschioni, Agnese Losurdo et al. · Breast Cancer Research · 2016 · 126 citations · Full text

Medicine, Immunology, Oncology +17

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Libero Santarpia, Yuan Qi, Katherine Stemke‐Hale et al. · Breast Cancer Research and Treatment · 2012 · 110 citations · Full text

Medicine, Molecular Genetics, Oncology +17